Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-10-06 15:59 |
Compugen to Present New Clinical and Research Data in Two Oral Presentations at…
|
English | 35.9 KB | ||
| 2022-09-22 15:59 |
Letter to Shareholders
|
English | 78.5 KB | ||
| 2022-09-22 15:59 |
Letter to Shareholders
|
English | 35.9 KB | ||
| 2022-09-15 15:59 |
6K: On September 14, 2022 the “Company held its 2022 Annual General Meeting of …
|
English | 52.5 KB | ||
| 2022-09-15 15:59 |
6K: On September 14, 2022 the “Company held its 2022 Annual General Meeting of …
|
English | 36.0 KB | ||
| 2022-09-12 15:59 |
Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer
|
English | 116.9 KB | ||
| 2022-09-12 15:59 |
Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer
|
English | 35.9 KB | ||
| 2022-09-07 15:59 |
Compugen to Participate in Upcoming Fierce Biotech Summit
|
English | 91.7 KB | ||
| 2022-09-07 15:59 |
Compugen to Participate in Upcoming Fierce Biotech Summit
|
English | 35.8 KB | ||
| 2022-08-24 15:59 |
Compugen Expands anti-PVRIG COM701 Patent Portfolio with New Composition of Mat…
|
English | 95.0 KB | ||
| 2022-08-24 15:59 |
Compugen Expands anti-PVRIG COM701 Patent Portfolio with New Composition of Mat…
|
English | 35.9 KB | ||
| 2022-08-08 15:59 |
Compugen Expands anti-PVRIG COM701 Intellectual Property Portfolio
|
English | 157.2 KB | ||
| 2022-08-08 15:59 |
Compugen Expands anti-PVRIG COM701 Intellectual Property Portfolio
|
English | 35.9 KB | ||
| 2022-08-04 16:39 |
FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 149.3 KB | ||
| 2022-08-04 16:39 |
FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 35.8 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
